129 related articles for article (PubMed ID: 31757642)
1. A novel NR3C2 polymorphism and the increased thyroid-stimulating hormone concentration are associated with venlafaxine treatment outcome in Chinese Han MDD patients.
Yuan F; Yuan R; Ren D; Bi Y; Niu W; Guo Z; Wu X; Xu F; Sun Q; Ma G; Yang F; Zhu Y; Yu T; Li X; He L; Shi L; He G
Psychiatry Res; 2020 Feb; 284():112690. PubMed ID: 31757642
[TBL] [Abstract][Full Text] [Related]
2. No association between CYP2C19 genetic polymorphism with treatment remission to antidepressant venlafaxine in Han Chinese population.
Zhang N; Ji L; Chen Z; An L; Ren D; Bi Y; Guo Z; Yuan R; Yuan F; Dong Z; Yin L; Sun X; Yang F; Li X; Yu T; He L; Shi L; He G
Psychiatr Genet; 2020 Feb; 30(1):30-33. PubMed ID: 31842058
[TBL] [Abstract][Full Text] [Related]
3. NR3C2 Gene is Associated with Susceptibility to High-Altitude Pulmonary Edema in Han Chinese.
Yang Y; Xu J; Tang F; Ga Q; Li Y; Guan W; Ge RL
Wilderness Environ Med; 2018 Dec; 29(4):488-492. PubMed ID: 30292562
[TBL] [Abstract][Full Text] [Related]
4. GRIK4 and GRM7 gene may be potential indicator of venlafaxine treatment reponses in Chinese of Han ethnicity.
Sun Q; Yuan F; Yuan R; Ren D; Zhu Y; Bi Y; Hu J; Guo Z; Xu F; Niu W; Ma G; Wu X; Yang F; Wang L; Li X; Yu T; He L; He G
Medicine (Baltimore); 2019 May; 98(19):e15456. PubMed ID: 31083176
[TBL] [Abstract][Full Text] [Related]
5. SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population.
Yeh YW; Chen CJ; Jang FL; Kuo SC; Chen CY; Liang CS; Ho PS; Yen CH; Shyu JF; Wan FJ; Lu RB; Huang SY
J Psychiatr Res; 2015 Feb; 61():33-9. PubMed ID: 25512257
[TBL] [Abstract][Full Text] [Related]
6. CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population.
Zhu Y; Zhang N; Ren D; Bi Y; Xu F; Niu W; Sun Q; Guo Z; Yuan R; Yuan F; Wu X; Cao Y; Yang F; Wang L; Du L; Li W; Xu Y; Li X; Zhu L; He L; Shi L; He G; Yu T
Clin Neuropharmacol; 2019; 42(2):32-36. PubMed ID: 30875344
[TBL] [Abstract][Full Text] [Related]
7. TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.
Yin L; Zhang YY; Zhang X; Yu T; He G; Sun XL
Pharmacopsychiatry; 2015 May; 48(3):95-103. PubMed ID: 25642918
[TBL] [Abstract][Full Text] [Related]
8. No Association Between SLC6A4 Gene Polymorphisms With Treatment Remission to Venlafaxine in Han Chinese Depressive Patients.
Wu N; Liu L; Ren D; Yuan F; Bi Y; Guo Z; Hou B; Ji L; Han K; Feng M; Su K; Yu T; Li X; Yang F; Sun X; Dong Z; Yu S; Yi Z; Xu Y; He L; Wu S; Zhao L; Changqun C; Shi Y; He G
Clin Neuropharmacol; 2021 Mar-Apr 01; 44(2):53-56. PubMed ID: 33480616
[TBL] [Abstract][Full Text] [Related]
9. Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression.
Bi Y; Ren D; Guo Z; Ma G; Xu F; Chen Z; An L; Zhang N; Ji L; Yuan F; Liu L; Hou B; Yang F; Yu S; Yi Z; Xu Y; He L; Sun X; Dong Z; Wu S; Zhao L; Cai C; Li X; Yu T; Shi Y; He G
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110036. PubMed ID: 32702381
[TBL] [Abstract][Full Text] [Related]
10. Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.
Marshe VS; Maciukiewicz M; Rej S; Tiwari AK; Sibille E; Blumberger DM; Karp JF; Lenze EJ; Reynolds CF; Kennedy JL; Mulsant BH; Müller DJ
Am J Psychiatry; 2017 May; 174(5):468-475. PubMed ID: 28068779
[TBL] [Abstract][Full Text] [Related]
11. [Association of CHRNA4 gene polymorphisms with response to antidepressant among ethnic Han Chinese].
Yu J; Dong Z; Yu T; Li X; Sun X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Dec; 36(12):1230-1234. PubMed ID: 31813155
[TBL] [Abstract][Full Text] [Related]
12. TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients.
Wang HC; Yeh TL; Chang HH; Gean PW; Chi MH; Yang YK; Lu RB; Chen PS
Psychopharmacology (Berl); 2011 Feb; 213(4):773-9. PubMed ID: 20945066
[TBL] [Abstract][Full Text] [Related]
13. Association of a Haplotype in the NR3C2 Gene, Encoding the Mineralocorticoid Receptor, With Chronic Central Serous Chorioretinopathy.
van Dijk EHC; Schellevis RL; van Bergen MGJM; Breukink MB; Altay L; Scholz P; Fauser S; Meijer OC; Hoyng CB; den Hollander AI; Boon CJF; de Jong EK
JAMA Ophthalmol; 2017 May; 135(5):446-451. PubMed ID: 28334414
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatment.
Su YA; Li JT; Dai WJ; Liao XM; Dong LC; Lu TL; Bousman C; Si TM
Int Clin Psychopharmacol; 2016 May; 31(3):127-33. PubMed ID: 26745768
[TBL] [Abstract][Full Text] [Related]
15. NR3C2 gene polymorphism is associated with risk of gestational hypertension in Han Chinese women.
Cui Z; Xu J; Jiang W
Medicine (Baltimore); 2019 Dec; 98(50):e18215. PubMed ID: 31852079
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure.
Ahmed AT; Biernacka JM; Jenkins G; Rush AJ; Shinozaki G; Veldic M; Kung S; Bobo WV; Hall-Flavin DK; Weinshilboum RM; Wang L; Frye MA
J Affect Disord; 2019 Mar; 246():62-68. PubMed ID: 30578947
[TBL] [Abstract][Full Text] [Related]
17. A neuropeptide Y variant (rs16139) associated with major depressive disorder in replicate samples from Chinese Han population.
Wang Y; Yang Y; Hui L; Tie C; Li F; Xu ZQ; Wang C
PLoS One; 2013; 8(2):e57042. PubMed ID: 23468908
[TBL] [Abstract][Full Text] [Related]
18. The sex-dependent role of the glucocorticoid receptor in depression: variations in the NR3C1 gene are associated with major depressive disorder in women but not in men.
Sarubin N; Hilbert S; Naumann F; Zill P; Wimmer AM; Nothdurfter C; Rupprecht R; Baghai TC; Bühner M; Schüle C
Eur Arch Psychiatry Clin Neurosci; 2017 Mar; 267(2):123-133. PubMed ID: 27549215
[TBL] [Abstract][Full Text] [Related]
19. Differences in immunomodulatory properties between venlafaxine and paroxetine in patients with major depressive disorder.
Chen CY; Yeh YW; Kuo SC; Liang CS; Ho PS; Huang CC; Yen CH; Shyu JF; Lu RB; Huang SY
Psychoneuroendocrinology; 2018 Jan; 87():108-118. PubMed ID: 29055264
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression.
Ng C; Sarris J; Singh A; Bousman C; Byron K; Peh LH; Smith DJ; Tan CH; Schweitzer I
Hum Psychopharmacol; 2013 Sep; 28(5):516-22. PubMed ID: 24014145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]